A new study found that people with scleroderma who have muscle weakness due to the accumulation of fibrous tissue in their muscles, are at risk for severe disease outcomes including death from heart disease.
Dr. Myma Albayda with the Johns Hopkins Arthritis Center highlights what’s involved in a joint injection.
In this issue of LEAP you can read about our precision approach to an increasingly common illness, gout, to a rare illness linked to Sjögren’s, and to cancer patients who are developing some autoimmune-mediated complications. And we are especially excited to share with you a tremendous breakthrough in understanding how rheumatoid arthritis begins.
Each year members of the Johns Hopkins Rheumatology team attend The American College of Rheumatology Conference. This year, we had the chance to connect with a few of our team members to discuss the research they presented at ACR 2016.
Laura is the nurse coordinator for the Johns Hopkins Arthritis Center working as a liaison between patients and physicians at the center.
Victoria is the Director of Patient Education and Director of Nursing at the Johns Hopkins Arthritis Center.
Anthony Keyes is the Research Program Manager at the Johns Hopkins Division of Rheumatology. Watch this video to learn about how he helps with research in our division.
Dr. Aucott is the Director of the recently launched Johns Hopkins Lyme Disease Clinical Research center. He shares his interest in Lyme Disease research and how he came to join the team at Johns Hopkins Rheumatology.
You may notice a theme to this issue of LEAP: change. Our cover story features research in Sjögren’s that has the potential to transform the way drugs are tested in clinical trials, to eliminate some of the time-consuming, trial-and-error process that is so familiar to patients and doctors alike, and even to lead to the development of new drugs that […]